Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
The protein encoded by ACSL4 is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Additionally we are shipping ACSL4 Proteins (9) and many more products for this protein.
Showing 10 out of 84 products:
Human Polyclonal ACSL4 Primary Antibody for IF, IHC (p) - ABIN389113
Rodriguez, Bhat, Meloni, Ladd, Leslie, Doyne, Renieri, Dupont, Stevenson, Schwartz, Srivastava: Intellectual disability, midface hypoplasia, facial hypotonia, and Alport syndrome are associated with a deletion in Xq22.3. in American journal of medical genetics. Part A 2010
Show all 7 references for ABIN389113
Human Polyclonal ACSL4 Primary Antibody for EIA, IF - ABIN357780
Area-Gomez, de Groof, Boldogh, Bird, Gibson, Koehler, Yu, Duff, Yaffe, Pon, Schon: Presenilins are enriched in endoplasmic reticulum membranes associated with mitochondria. in The American journal of pathology 2009
Show all 2 references for ABIN357780
Human Polyclonal ACSL4 Primary Antibody for ELISA, WB - ABIN184846
Piccini, Vitelli, Bruttini, Pober, Jonsson, Villanova, Zollo, Borsani, Ballabio, Renieri: FACL4, a new gene encoding long-chain acyl-CoA synthetase 4, is deleted in a family with Alport syndrome, elliptocytosis, and mental retardation. in Genomics 1998
Cow (Bovine) Polyclonal ACSL4 Primary Antibody for WB - ABIN2783895
Hu, Chen, Jiang, Li, Wang: The effect of fatty acid-CoA ligase 4 on the growth of hepatic cancer cells. in Cancer biology & therapy 2008
Human Polyclonal ACSL4 Primary Antibody for WB - ABIN658327
Zeman, Vecka, Jáchymová, Jirák, Tvrzická, Stanková, Zák: Fatty acid CoA ligase-4 gene polymorphism influences fatty acid metabolism in metabolic syndrome, but not in depression. in The Tohoku journal of experimental medicine 2009
we demonstrate that ACSL4 can be considered a novel activator of the mTOR (show FRAP1 Antibodies) pathway
In vitro analysis showed that a recombinant COX-2 (show COX2 Antibodies) enzyme more effectively metabolized 5(S)-HETE to 5-11-diHETE compared to COX-1 (show COX1 Antibodies) enzyme.
Upregulation of ACSL4 is responsible for the increase in triacylglycerol species containing long polyunsaturated fatty acids during activation of hepatic stellate cells.
Report PPARdelta (show PPARD Antibodies)-mediated regulatory mechanism for ACSL4 expression in liver tissue and cultured hepatic cells.
ACSL4 can serve as both a biomarker for, and mediator of, an aggressive breast cancer phenotype.
This study found no significant relationship between FACL4 and cognitive function.
conclude that in our model system exogenous fatty acids are channeled preferentially towards phosphatidylinositol by ACSL4 overexpression
MiR (show MLXIP Antibodies)-205 down-regulates ACSL4 through targeting its 3'UTR (show UTS2R Antibodies) in hepatoma cells.
The functional interaction between Acyl-CoA synthetase 4, 5-lipooxygenase and cyclooxygenase-2 (show PTGS2 Antibodies) controls tumor growth.
the involvement of SHP2 (show PTPN11 Antibodies) activity in the regulation of the expression of the fatty acid-metabolizing enzyme ACSL4
Sequence analysis of a 1.5-kb fragment of the Acsl4 promoter revealed the absence of a TATA box and the presence of many putative binding sites for transcription factors including Sp1 (show SP1 Antibodies) and CREB (show CREB1 Antibodies).
Acsl4 is a phosphoprotein whose phosphorylation is hormone-dependent.
These results indicate that the ACS4 protein specifically expressed in brain plays an important role in arachidonate metabolism and neuronal differentiation in the brain.
Results indicate that fatty acid binding protein H-FABP (show FABP3 Antibodies) and CoA ligase 4 ACSL4 genes might serve as markers to improve fat (IMF (show MDFI Antibodies)) content in the breeding system.
ACSL4 Single Nucleotide Polymorphism G2645A is associated with several meat quality traits.
Polymorphisms within the ACSL4 gene are associated with growth and meat quality.
The analyses of mutant lines revealed strongly overlapping functions of LACS4 and LACS9 in lipid trafficking from the endoplasmic reticulum to the plastid.
The combined inactivation of LACS1 (show Acsl1 Antibodies) and LACS4 in Arabidopsis resulted in conditional pollen sterility and impaired wax biosynthesis.
The protein encoded by this gene is an isozyme of the long-chain fatty-acid-coenzyme A ligase family. Although differing in substrate specificity, subcellular localization, and tissue distribution, all isozymes of this family convert free long-chain fatty acids into fatty acyl-CoA esters, and thereby play a key role in lipid biosynthesis and fatty acid degradation. This isozyme preferentially utilizes arachidonate as substrate. The absence of this enzyme may contribute to the mental retardation or Alport syndrome. Alternative splicing of this gene generates 2 transcript variants.
acyl-CoA synthetase long-chain family member 4
, long-chain-fatty-acid--CoA ligase 4
, Long-chain-fatty-acid--CoA ligase 4
, long-chain-fatty-acid--CoA ligase 4-like
, LACS 4
, acyl-CoA synthetase 4
, fatty-acid-Coenzyme A ligase, long-chain 4
, lignoceroyl-CoA synthase
, long-chain acyl-CoA synthetase 4
, long-chain fatty-acid-Coenzyme A ligase 4
, fatty acid-Coenzyme A ligase, long chain 4
, fatty acid Coenzyme A ligase, long chain 4
, fatty acid-Coenzyme A ligase long chain 4
, acyl-CoA synthetase long-chain family member 3